Arbidol is a broad-spectrum antiviral that blocks viral entry by inhibiting virus-mediated fusion, with distinct mechanisms for influenza and HCV.
No takes yet. Share an insight, caveat, or question.
Advances antiviral entry inhibition strategies; leaves open clinical utility pending randomized trials.
Boriskin et al. (2008) studied this question.